Useful Links

STADA Arzneimittel AG
Thornton & Ross is a company of STADA Arzneimittel AG.
The headquarters of STADA are located in Bad Vilbel, Germany.

STADA Arzneimittel AG

PAGB - Proprietary Association of Great Britain
Represents the manufactures of over-the-counter medicines and food supplements in the United Kingdom.

EMC - Electronic Medicines Companion
This site provides the UK approved information sheets for licensed medicines. Including patient information leaflets and SPCs.

Thornton and Ross - Health and Saftey Policy
Thornton and Ross Ltd have a duty to protect and promote the health, safety and wellbeing of our employees as well as visitors to the company’s premises
Health and Safety Policy

Thornton and Ross - Company Environmental Policy
Thornton and Ross Ltd is an environmentally conscious organisation accredited to ISO 14001.
Company Environmental Policy

Thornton and Ross - Modern Slavery Act 2015: Transparency in Supply Chain
As part of our Vendor Rating Questionnaire, we question our suppliers to confirm whether they have a program to assure that human trafficking and slavery do not exist in their operations or their supply chain.
Modern Slavery Policy

Stada Group UK - Tax Strategy
Thornton and Ross follow the STADA Group UK Tax Strategy and Policies.
Group Tax Strategy

Brand Websites

Care Hedrin Cetraben T + R Derma
Care Zoflora Metanium Movelat
Crampex Eucryl Virasoothe Acriflex
Algesal Allens Aquamol Radian B
Cerumol Setlers Itcheze Mycota


Leading pharmaceutical company invests in seven-figure state-of-the-art facility

Huddersfield pharmaceutical company Thornton & Ross is expanding, with a new seven-figure state-of-the-art facility due to open at the beginning of January.

Click for more info

Thornton & Ross triumphant in industry awards

Huddersfield-based pharmaceutical company Thornton & Ross has received national recognition for six of its products at the national 2019 ‘Most Valuable Product’ (MVP) Awards in pharmacy.

Click for more info

Thornton & Ross launches alternative, cost-effective treatment for osteoporosis in UK

West Yorkshire-based pharmaceutical company Thornton & Ross (T&R) is launching an alternative, cost-effective treatment for osteoporosis.

Click for more info

Thornton & Ross to acquire established GSK Consumer Health brands

Thornton & Ross has expanded its Consumer Health business with a contract to acquire four UK skin care brands, as well as a paediatric cough remedy, from GlaxoSmithKline. Completion of the deal is expected to occur by August 2019.

Click for more info

Peter Goldschmidt to succeed Claudio Albrecht as STADA’s CEO

STADA Arzneimittel AG Appoints Peter Goldschmidt as CEO to suceed Claudio Albrecht.

Click for more info

STADA acquires EMEA rights to global anti-dandruff brand Nizoral from Janssen Pharmaceutica

STADA Arzneimittel AG is further strengthening its position in branded over-the-counter healthcare products.

Click for more info

Ladival wins 'Best Beach Sun Protection 2017'

Thornton & Ross is pleased to announce that Ladival Sun Protection Lotion SPF30 has won the 'Best Beach Sun Protection' in this year's Best Beauty by Stylist Awards 2017.

Click for more info

Thornton & Ross Ltd signs licensing agreement with Futura Medical

Thornton & Ross is pleased to announce it has entered in to a long-term licensing agreement with Futura Medical.

Click for more info

>> News Archive